Technology for natural anti-asthmatic drug transferred to Hankuk Shinyak.

Published: 2003-02-24 06:56:00

Updated: 2003-02-24 06:56:00

Korea Bio Engineering Research Institute (KBERI) has developed an anti-asthmatic drug from the extracts of Yulan magnolid, a natural herb, under the government (MOST) financial subsidy (1 billion won) as one of the G7 projects, and recently made an exclusive distribution agreement with Hankuk Shi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK